SK29295A3 - 4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use - Google Patents

4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use Download PDF

Info

Publication number
SK29295A3
SK29295A3 SK292-95A SK29295A SK29295A3 SK 29295 A3 SK29295 A3 SK 29295A3 SK 29295 A SK29295 A SK 29295A SK 29295 A3 SK29295 A3 SK 29295A3
Authority
SK
Slovakia
Prior art keywords
hydrogen
phenyl
amide
methyl
cooch
Prior art date
Application number
SK292-95A
Other languages
English (en)
Slovak (sk)
Inventor
Farmaceutska Kemijska Pr Pliva
Mice Kovacevic
Jure Herak
Zora Mandic
Irena Lukic
Mirjana Tomic
Zinka Brkic
Original Assignee
Pliva Handels Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Handels Gmbh filed Critical Pliva Handels Gmbh
Publication of SK29295A3 publication Critical patent/SK29295A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
SK292-95A 1992-09-08 1993-09-08 4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use SK29295A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4230053A DE4230053A1 (de) 1992-09-08 1992-09-08 4-Oxo-azetidin-2-sulfonsäureamide und ihre Salze, Verfahren zu deren Herstellung und ihre Verwendung
PCT/EP1993/002428 WO1994005632A1 (de) 1992-09-08 1993-09-08 4-oxo-azetidin-2-sulfonsäurenamide und ihre salze, verfahren zu deren herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
SK29295A3 true SK29295A3 (en) 1995-09-13

Family

ID=6467533

Family Applications (1)

Application Number Title Priority Date Filing Date
SK292-95A SK29295A3 (en) 1992-09-08 1993-09-08 4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use

Country Status (19)

Country Link
US (1) US5466686A (zh)
EP (1) EP0659177B1 (zh)
JP (1) JPH08501093A (zh)
CN (1) CN1042130C (zh)
AT (1) ATE187441T1 (zh)
BG (1) BG62135B1 (zh)
CA (1) CA2142275A1 (zh)
CZ (1) CZ54595A3 (zh)
DE (2) DE4230053A1 (zh)
ES (1) ES2142350T3 (zh)
GR (1) GR3032702T3 (zh)
HR (1) HRP930613A2 (zh)
HU (1) HU217979B (zh)
PL (1) PL173895B1 (zh)
PT (1) PT659177E (zh)
RO (1) RO115256B1 (zh)
RU (1) RU2124003C1 (zh)
SK (1) SK29295A3 (zh)
WO (1) WO1994005632A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP921292A2 (en) * 1992-11-17 1994-08-31 Pliva Pharm & Chem Works 5-thia-1,4-diazabicyclo (4.2.0.)octane -3,8-dioxo analogs of beta-lactams, the process for the preparation and use thereof
HRP970146A2 (en) * 1997-03-13 1998-10-31 Mice Kovacevic Epoxi-azetidines, preparation and use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR59922B (en) * 1974-12-24 1978-03-20 Lilly Co Eli Process for preparing 3-methylene cepham
JPS58210060A (ja) * 1982-05-31 1983-12-07 Takeda Chem Ind Ltd ２−オキソアゼチジン誘導体、その製造法および用途
US4436596A (en) * 1982-11-16 1984-03-13 Eli Lilly And Company N-Substituted-2-(R)-(sulfinic acid)-3-(S)-(acylamido)-4-oxo-azetidines and process
RU2043988C1 (ru) * 1991-02-12 1995-09-20 Плива Хандельс ГмбХ 4-оксоазетидин-2-сульфоновые кислоты или их соли в качестве промежуточных продуктов в синтезе бета-лактамовых антибиотиков и способ их получения

Also Published As

Publication number Publication date
CA2142275A1 (en) 1994-03-17
CN1099750A (zh) 1995-03-08
DE4230053A1 (de) 1994-03-10
GR3032702T3 (en) 2000-06-30
HUT73528A (en) 1996-08-28
RU2124003C1 (ru) 1998-12-27
CN1042130C (zh) 1999-02-17
PL307851A1 (en) 1995-06-26
RU95111375A (ru) 1997-03-20
DE59309898D1 (de) 2000-01-13
ATE187441T1 (de) 1999-12-15
RO115256B1 (ro) 1999-12-30
BG99296A (bg) 1995-12-29
ES2142350T3 (es) 2000-04-16
HRP930613A2 (en) 1998-06-30
HU217979B (hu) 2000-05-28
WO1994005632A1 (de) 1994-03-17
EP0659177B1 (de) 1999-12-08
BG62135B1 (bg) 1999-03-31
CZ54595A3 (en) 1995-12-13
US5466686A (en) 1995-11-14
HU9500694D0 (en) 1995-04-28
JPH08501093A (ja) 1996-02-06
EP0659177A1 (de) 1995-06-28
PT659177E (pt) 2000-04-28
PL173895B1 (pl) 1998-05-29

Similar Documents

Publication Publication Date Title
CZ192297A3 (en) Substituted azetidin-2-ones for treating atherosclerosis, process of their preparation and use
JP2019210273A (ja) エドキサバンの製造方法
CA2225627A1 (en) Azetidinone derivatives for the treatment of atherosclerosis
CS243499B2 (en) Method of new beta-lactams production
US4427586A (en) 2-Oxoazetidine derivatives and production thereof
SK29295A3 (en) 4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use
EP1099690A1 (en) MONOCYCLIC $g(b)-LACTAM COMPOUNDS AND CHYMASE INHIBITORS CONTAINING THE SAME
JPS61176563A (ja) ４，４‐ジアルキル‐２‐アゼチジノン類の製造法
HU211844A9 (en) 4-oxo-azetidine-2-sulfonic acids and their salts, processes for the preparation thereof and their use
JPS6023363A (ja) Ｎ−（置換メチル）−アゼチジン−２−オン類
EP0256763B1 (en) Process for azetidinones
JPH01100168A (ja) ２−オキソ−１−［［（置換スルホニル）アミノ］カルボニル］アゼチジン類
KR850001879B1 (ko) 4-플루오로 아제티디논의 제조방법
JPS6019763A (ja) アゼチジノンチオエステル類の製造法
SI9300003A (sl) Amidi 4-okso-azetidin-2-sulfonskih kislin in njihove soli, postopki za njihovo pripravo in njihova uporaba
EP0187500B1 (en) Monobactams
KR810001820B1 (ko) 세펨 화합물 유도체의 제조 방법
JPS5931787A (ja) １，３，２−オキサアザホスホリナン−２−オキシド誘導体
CZ245193A3 (en) 5-thia-1,4-diazabicyclo/4,2,0/octane-3,8-dioxo analogs of beta lactams, process of their preparation and their use
PL175991B1 (pl) Nowe 5-tia-1,4-diazabicyklo [4.2.0] oktano-3,8-diokso-analogi beta-laktamów, sposób ich wytwarzania
WO1987000527A1 (en) Antibacterial compounds, their use, and process for their preparation
JPH0315627B2 (zh)
JPH02247182A (ja) 新規６―アミド―１―メチルカルバペナム類
SK30498A3 (en) Epoxy - azetidinones, the preparation and use thereof
HRP970713A2 (en) 7-bromo- and 7,7 dibromo-cepham and cephem derivatives